248 related articles for article (PubMed ID: 11927013)
21. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
[TBL] [Abstract][Full Text] [Related]
22. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
Ahmed RA; Shawky Ael-A; Hamed RH
Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
[TBL] [Abstract][Full Text] [Related]
24. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
25. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
Wang X; Wang Z; Lu WL; Zhao GF
Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
[No Abstract] [Full Text] [Related]
26. Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients.
Jia Y; Wang H; Wang Y; Wang T; Wang M; Ma M; Duan Y; Meng X; Liu L
Int J Cancer; 2015 Sep; 137(5):1095-106. PubMed ID: 25683635
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma.
Li B; Chen H; Xiang J; Zhang Y; Kong Y; Garfield DH; Li H
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1198-203. PubMed ID: 23988285
[TBL] [Abstract][Full Text] [Related]
28. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases.
Eguchi T; Nakanishi Y; Shimoda T; Iwasaki M; Igaki H; Tachimori Y; Kato H; Yamaguchi H; Saito D; Umemura S
Mod Pathol; 2006 Mar; 19(3):475-80. PubMed ID: 16444191
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of subcarinal lymph node metastasis in patients with esophageal squamous cell carcinoma.
Feng JF; Zhao Q; Chen QX
Asian Pac J Cancer Prev; 2013; 14(5):3183-6. PubMed ID: 23803101
[TBL] [Abstract][Full Text] [Related]
30. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis.
Araki K; Ohno S; Egashira A; Saeki H; Kawaguchi H; Sugimachi K
Cancer; 2002 Jan; 94(2):570-5. PubMed ID: 11900242
[TBL] [Abstract][Full Text] [Related]
31. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Okada M
Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
[TBL] [Abstract][Full Text] [Related]
32. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
[TBL] [Abstract][Full Text] [Related]
33. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
34. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma.
Kim HS; Won KY; Kim GY; Kim SC; Park YK; Kim YW
Pathol Res Pract; 2012 May; 208(5):292-9. PubMed ID: 22464151
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
Sgourakis G; Gockel I; Lang H
World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the proliferative activity of superficial esophageal carcinoma using MIB-1 immunostaining for the Ki-67 antigen.
Chino O; Makuuchi H; Shimada H; Machimura T; Mitomi T; Osamura RY
J Surg Oncol; 1998 Jan; 67(1):18-24. PubMed ID: 9457251
[TBL] [Abstract][Full Text] [Related]
37. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings.
Kawamura T; Goseki N; Koike M; Takizawa T; Endo M
Cancer; 1996 Mar; 77(5):843-9. PubMed ID: 8608473
[TBL] [Abstract][Full Text] [Related]
38. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
39. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
40. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
